1Vatter H,Seifert V.Ambrisentan a non-peptide endothelin receptor antagonist.Cardiovasc Drug Rev,2006,24:63-76.
2Barst RJ,Langleben D,Badesch D,et al.Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.Journal of the American College of Cardiology,2006,47:2049-2056.
3Wilkins MR,Paul GA,Strange JW,et al.Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.Am J Respir Crit Care Med,2005,171:1292-1297.
4Xia Z,Kuo KH,McNeill JH,et al.Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat:critical timing of administration.Canadian Journal of Physiology and Pharmacology,2005,83:259-266.
5Gupta SK,Saxena A,Singh U,et al.Bosentan,the mixed ETA-ETB endothelin receptor antagonist,attenuateed oxidative stress after experimental myocardial ischemia and reperfusion.Mol Cell Biochem,2005,275:67-74.
6Bohm F,Settergren M,Gonon AT,et al.The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans.Clinical Science,2005,108:357-363.
7Prasad SK,Dargie HJ,Smith GC,et al.Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction:a cardiovascular magnetic resonance study.Heart,2006,92:798-803.
8Cotter G,Kaluski E,Stangl K,et al.The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure.Eur J Heart Fail,2004,6:601-609.
9Vatter H,Zimmermann M,Tesanovic V,et al.Cerebrovascular characterization of clazosentan,the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm.Part II:effect on endothelin(B) receptor-mediated relaxation.J Neurosurg,2005,102:1108-1114.
10Vajkoczy P,Meyer B,Weidauer S,et al.Clazosentan (AXV-034343),a selective endothelin A receptor antagonist,in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage:results of a randomized,double-blind,placebo-controlled,multicenter phase IIa study.J Neurosurg,2005,103:9-17.
6Foitzik T, Faulhaber J, Hotz HG, et al. Endothelin mediates local and systemic disease sequelae in severe experimental pancreatitis. Pancreas, 2001,22:248-254.
7Housset C,Rockey DC, Bisseum, et al, Endothel in receptorin the liver: lipocytes as a contractile target for endothelia-1. Proc Natl Acad Sci USA, 1993,90:9266.
